#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Vaginal cancer Partial lipodystrophy Breast cancer Pleomorphic liposarcoma Cluster headache Familial haemophagocytic lymphohistiocytosis Cutaneous T-cell lymphoma refractory B-cell lymphoma refractory Penile cancer Metabolic disorder Adult T-cell lymphoma/leukaemia refractory Usher's syndrome Cerebellar ataxia Infantile apnoea Thrombotic thrombocytopenic purpura More trials…
Learn about Rare Diseases

Nodal marginal zone B-cell lymphoma – Treatment Erdheim-Chester disease Malignant fibrous histiocytoma – Treatment Waldenstrom’s macroglobulinaemia – Basic Information Noonan syndrome – Diagnostics Rhabdomyosarcoma – Diagnostics Langerhans’ cell histiocytosis – Life with Disease Adrenogenital syndrome – Diagnostics Systemic mastocytosis – Diagnostics Phenylketonuria – Basic Information More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

Baricitinib Sabatolimab Divarasib AZD5335 Haemophilus Influenzae Rusfertide SEVUPARIN Art0380 Mesilate Bedaquiline Bgb-A445 Absk021 Hydrochloride Hydrate Tilsotolimod Sodium Vobramitamab Duocarmazine Botaretigene Sparoparvovec Ralinepag Omp66 VTX-002 Rbl007.2 Valaciclovir Ripretinib More therapies…

Learn about Your Condition

Non-obstructive cardiomyopathy Large cell lung cancer Stevens-Johnson syndrome Dyslipidaemia Hepatobiliary disease Thymoma Prodromal Alzheimer's disease Cutaneous lupus erythematosus Factor VIII deficiency Porphyria non-acute Atrial septal defect Necrotising myositis Mechanical ventilation Toxic epidermal necrolysis Primary hyperaldosteronism More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Tuberculosis

Study on High-Dose Rifampicin Safety for Adults with Complex Tuberculosis Using Isoniazid, Pyrazinamide, and Ethambutol Combination

Recruiting

2 1 1 1
Investigated Diseases:
- Tuberculosis
Investigated Drugs:
Study on the Effects of Tedizolid and Linezolid for Patients with Suspected Lung Tuberculosis

Recruiting

2 1 1 1
Investigated Drugs:
Study on the Safety and Tolerability of Higher Dose Rifampicin for Tuberculosis Patients

Not yet recruiting

3 1 1 1
Investigated Drugs:
- Rifampicin
Study on Higher Doses of Rifampicin and Pyrazinamide for Shortened Treatment of Mild-to-Moderate Tuberculosis in Patients with Drug-Sensitive Pulmonary TB

Not yet recruiting

2 1 1 1
Investigated Diseases:
- Tuberculosis
Investigated Drugs:
- Pyrazinamide
- Rifampicin

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Tuberculosis

Study on High-Dose Rifampicin Safety for Adults with Complex Tuberculosis Using Isoniazid, Pyrazinamide, and Ethambutol Combination

Study on the Effects of Tedizolid and Linezolid for Patients with Suspected Lung Tuberculosis

Study on the Safety and Tolerability of Higher Dose Rifampicin for Tuberculosis Patients

Study on Higher Doses of Rifampicin and Pyrazinamide for Shortened Treatment of Mild-to-Moderate Tuberculosis in Patients with Drug-Sensitive Pulmonary TB

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies